5-[4-[1-[(4-bromophenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-2-(4-fluorophenyl)-4-methyl-1,3-thiazole
C28H20BrFN6S — CID 155563539
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[1-[(4-bromophenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-2-(4-fluorophenyl)-4-methyl-1,3-thiazole
5-[4-[1-[(4-bromophenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-2-(4-fluorophenyl)-4-methyl-1,3-thiazole (PubChem CID 155563539) has the molecular formula C28H20BrFN6S and a molecular weight of 571.48 g/mol. Its IUPAC name is 5-[4-[1-[(4-bromophenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-2-(4-fluorophenyl)-4-methyl-1,3-thiazole.
Molecular Properties
| Compound Name | 5-[4-[1-[(4-bromophenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-2-(4-fluorophenyl)-4-methyl-1,3-thiazole |
|---|---|
| PubChem CID | 155563539 |
| Molecular Formula | C28H20BrFN6S |
| Molecular Weight | 571.48 g/mol |
| Exact Mass | 570.06 |
| IUPAC Name | 5-[4-[1-[(4-bromophenyl)methyl]triazol-4-yl]-1-phenylpyrazol-3-yl]-2-(4-fluorophenyl)-4-methyl-1,3-thiazole |
| SMILES | Cc1nc(-c2ccc(F)cc2)sc1-c1nn(-c2ccccc2)cc1-c1cn(Cc2ccc(Br)cc2)nn1 |
| InChI | InChI=1S/C28H20BrFN6S/c1-18-27(37-28(31-18)20-9-13-22(30)14-10-20)26-24(16-36(33-26)23-5-3-2-4-6-23)25-17-35(34-32-25)15-19-7-11-21(29)12-8-19/h2-14,16-17H,15H2,1H3 |
| InChIKey | KHDXWVSPRDEJQT-UHFFFAOYSA-N |
| XLogP | 7.18 |
| TPSA | 61.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 571.48 |
| LogP ≤ 5 | 7.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155563539 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.